YING-JA (INCA) CHEN, PHD（陳映嘉博士）
Research Fellow, Bioinformatics
Intellectual Property Manager
Ying-Ja (Inca) Chen is currently a Research Fellow in the Bioinformatics Division at ACT Genomics and leads the effort in biomarker discovery for cancer immunotherapy. She is also a U.S. patent agent and oversees the intellectual property portfolio at ACT Genomics. Previously, she has held positions in Discovery and Intellectual Property at Axcella Health. Inca received her B.Sc. in Electrical Engineering from National Taiwan University, Ph.D. in Bioengineering from University of California, San Diego and completed postdoctoral fellowship at Massachusetts Institute of Technology.
About ACT Genomics 行動基因
ACT Genomics is the world’s leading cancer solution provider. Based in Taiwan, ACT also provides effective services through our offices in Singapore, Hong Kong, Shanghai and Tokyo. Joint by experts from the field of cancer biology, cancer genomics and bioinformatics, ACT provides optimal cancer treatment plan, cancer relapse and drug resistance monitoring as well as cancer risk assessment and immunotherapy evaluation. ACT is dedicated to provide every cancer patient personalized genomic information based-treatment plans through their cutting-edge Next Generation Sequencing (NGS) platform, medical report and integrated services.